CRISPR Therapeutics AG ($CRSP) Stock Forecast: Up 6.2% Today

What is CRISPR Therapeutics AG?

CRISPR Therapeutics AG (CRSP) is a biotechnology company focused on developing gene-based medicines using CRISPR technology. Today, the stock had a strong bullish movement.

Why is CRISPR Therapeutics AG going up?

CRSP stock is up 6.2% on Sep 18, 2025 18:36

• Despite falling more steeply than the broader market in the previous trading session, CRSP closed with a significant bullish movement today.
• The -3.46% move from the previous day might have been a temporary correction or profit-taking by some investors.
• The bullish movement today could be attributed to positive factors like a successful clinical trial, a new partnership, or overall market optimism towards the biotechnology sector.
• Investors in CRSP need to stay updated with the latest developments in the company and the broader biotech industry to make informed decisions.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

CRISPR Therapeutics AG ( CRSP ) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $59.07, marking a -3.46% move from the previous day.

https://www.zacks.com/stock/news/2753092/crispr-therapeutics-ag-crsp-falls-more-steeply-than-broader-market-what-investors-need-to-know

Trending Today

Intel Corporation ($INTC) Stock Forecast: Up 22.9% Today

Kornit Digital Ltd. ($KRNT) Stock Forecast: Up 5.2% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Up 25.5% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 5.2% Today

Dogecoin ($DOGE) Crypto Forecast: Up 7.4% Today

Jefferies Financial Group Inc. ($JEF) Stock Forecast: Up 5.7% Today

BlackBerry Limited ($BB) Stock Forecast: Up 5.8% Today

CRISPR Therapeutics AG ($CRSP) Stock Forecast: Up 6.2% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Up 5.3% Today

Tilray Inc. ($TLRY) Stock Forecast: Up 5.4% Today

CRISPR Therapeutics AG Price History

11.06.2025 - CRSP Stock was down 5.2%

• Despite recent positive developments for CRISPR Therapeutics, including promising early data for CTX310, the stock saw a downward trend today.
• Increased trading volume and share price fluctuations may have triggered profit-taking among investors, leading to the stock's decline.
• Analyst ratings varying widely and a broad price target range could have contributed to uncertainty and volatility in the stock's performance.
• External factors such as overall market conditions or sector-specific influences might have also impacted CRSP's decrease, with the stock ending lower than the previous close with a -1.88% change.

09.06.2025 - CRSP Stock was up 5.4%

• CRSP stock exhibited a noteworthy bullish surge, defying the general market trend.
• The surge in stock value could be linked to favorable developments within the company, potentially associated with advancements in its gene-editing technology.
• Despite the market experiencing a downturn, CRSP remained resilient, underscoring strong investor confidence in the company's future trajectory.
• The optimistic outlook toward groundbreaking technologies and advancements in biotech, as evidenced by ARKK reaching a 52-week peak, likely played a role in the surge of CRSP stock.

30.05.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics AG (CRSP) saw a significant bullish movement today, closing at $47.66, up 1.88% from the previous trading session.
• The stock outperformed the market, finishing at $46.78, reflecting a +2.7% change from the day before.
• The positive momentum may be linked to increasing investor confidence in CRISPR technology and its potential applications in gene-based medicine.
• The company's recent progress in its research and development pipeline could also be influencing the positive sentiment surrounding the stock.

05.07.2025 - CRSP Stock was down 5.2%

• CRISPR Therapeutics (CRSP) stock closed at $56.26 today, showing a bearish movement of -2.46% from the previous trading day.
• The decline in CRSP stock price is linked to the company's wider second-quarter loss, mainly due to expenses related to the Sirius deal.
• Investors may view the company's emphasis on increasing Casgevy adoption as a risky move amidst current market conditions.
• Market sentiment towards CRSP appears more negative compared to the broader market, reflecting specific concerns about the company's financial performance and strategic choices.

04.07.2025 - CRSP Stock was up 5.7%

• Despite a recent slight decline in trading, CRSP demonstrated strong bullish movement overall.
• Some investors engaged in profit-taking, causing a temporary dip in CRSP's stock price following a period of significant growth.
• The positive momentum in CRSP is likely fueled by advancements in the company's gene-based medicine portfolio, driving up investor confidence.
• While a general market decline had a limited impact on CRSP's stock price, the prevailing positive outlook on the company remains steadfast.

29.06.2025 - CRSP Stock was down 7.5%

• Investor caution may be linked to CRISPR Therapeutics' upcoming Q2 earnings report, with focus on Casgevy sales growth and advancements in its gene-editing pipeline.
• The decline in stock value could stem from traders taking profits, particularly following a recent market uptrend, suggesting a short-term adjustment.
• Market dynamics may also be influenced by general market trends or industry-specific developments affecting biotechnology stocks, contributing to the bearish sentiment surrounding CRSP today.

25.06.2025 - CRSP Stock was down 5.2%

• Factors contributing to the downward movement in CRSP stock include:
• Despite the market's upward trajectory, CRSP stock experienced a decline, suggesting investor profit-taking.
• The 3.05% decrease in CRSP's stock price may be linked to overall market instability affecting biotech companies.
• Investors' actions may be influenced by recent developments concerning CRISPR Therapeutics AG, leading to a sell-off of the stock.

08.06.2025 - CRSP Stock was up 5.2%

• The bearish movement in CRSP stock can be attributed to:
• Profit-taking by investors following a recent uptrend in the stock price
• General market volatility resulted in a pullback in high-growth biotech stocks
• Potential concerns or uncertainties about the company's pipeline or future prospects

16.08.2025 - CRSP Stock was up 5.3%

• Factors contributing to the bullish movement in CRSP stock today include:
• The bullish trend in the market prompting investors to purchase CRSP despite a minor decline in the previous trading session.
• Positive news or advancements in CRSP's gene editing technologies or pipeline boosting investor confidence.
• Strong financial performance and positive future outlook attracting more buyers.
• Possible partnerships or collaborations in the biotech sector involving CRSP piquing investor interest and driving up the stock price.

10.06.2025 - CRSP Stock was up 5.7%

• CRISPR Therapeutics (CRSP) saw a strong bullish movement today, with shares surging by 9.6%.
• The surge in CRSP's shares could be attributed to higher than average trading volume and positive market sentiment.
• Despite concerns about the latest trend in earnings estimate revisions not translating into further price increase in the near term, investors showed confidence in the stock.
• The negative sentiment in the broader market did not impact CRSP's performance, indicating strong investor interest in the company's innovative biotech solutions.

18.06.2025 - CRSP Stock was up 15.0%

• Key points for the bearish movement in CRSP stock:
• CRSP declining more than the overall market, indicating specific company-related factors at play.
• Investors might have reacted negatively to certain information or developments within the company.
• The -6.54% drop in CRSP's stock price could have triggered profit-taking or stop-loss orders, further exacerbating the decline.
• It is essential for investors to closely monitor any news or updates from CRISPR Therapeutics AG to make informed decisions regarding their investments in the company.

18.08.2025 - CRSP Stock was up 6.2%

• Despite falling more steeply than the broader market in the previous trading session, CRSP closed with a significant bullish movement today.
• The -3.46% move from the previous day might have been a temporary correction or profit-taking by some investors.
• The bullish movement today could be attributed to positive factors like a successful clinical trial, a new partnership, or overall market optimism towards the biotechnology sector.
• Investors in CRSP need to stay updated with the latest developments in the company and the broader biotech industry to make informed decisions.